Scientific Advisory Board


George C. Fahey, Jr., PhD

Professor Emeritus of Animal Sciences and the Kraft Foods Endowed Professor Emeritus of Nutritional Sciences at the University of Illinois at Urbana-Champaign.

Frank Greenway, MD

Professor and Medical Director of the Clinical Trials Research Unit of the Pennington Biomedical Research Center in Baton Rouge, Louisiana. Dr. Greenway’s area of research is in the treatment of obesity with an emphasis on pharmacological and nutraceutical interventions.

John Finley, Ph.D.

Adjunct Professor in the School of Nutrition and Food Science, Louisiana State University Agricultural Center and Pennington Biomedical Research Center at LSU. Dr. Finley’s research interests include low calorie ingredients, anti-inflammatory compounds in the diet and modified lipids.  His current research interests include how food ingredients interact with the microbiome.  Previously, Dr. Finley developed several low-calorie technologies and satiety enhancing products as a fellow at Kraft Foods. Earlier, he served as chief technology officer of A.M. Todd Co. Dr. Finley also served as the leader of the Food Science program at Monsanto, which was focused on delivery of intense sweeteners and development of reduced calorie ingredients. Earlier, at Nabisco Dr. Finley assembled and led the Fundamental Science program. Dr. Finley has authored over 100 technical publications, edited 11 books and holds over 50 patents. Currently he is an Associate Editor for the Journal of Agricultural and Food Chemistry.

Vivian A. Fonseca, MD, FRCP

Professor of Medicine, the Tullis–Tulane Alumni Chair in Diabetes, and Chief of the Section of Endocrinology at Tulane University Medical Center in New Orleans. He currently serves on the Board of Directors of the American Association of Clinical Endocrinologists, and the Board of Trustees of the American College of Endocrinology. Dr. Fonseca is a Past President for Science and Medicine of the American Diabetes Association, and has held a leadership role and served on various committees in several other organizations including the American Diabetes Association, the American College of Endocrinology and the American Board of Internal Medicine.

He is Editor in Chief of the Journal of Diabetes and its Complications. He was Editor in Chief of Diabetes Care from 2007-2011.  Until 2006 Dr. Fonseca was Editor in Chief of the Journal of the Metabolic Syndrome and Related Disorders. He served on the editorial board of the Journal of Clinical Endocrinology and Metabolism, and is an ad hoc reviewer for several other journals, including New England Journal of Medicine, Lancet, JAMA, Diabetes, etc.

Dr. Fonseca is a fellow of the American Association of Clinical Endocrinologists, the Royal College of Physicians (London), and the American College of Physicians. Dr. Fonseca has served on and been chairman of the clinical practice committee of the American Diabetes Association, the ADA Disaster Task Force, ADA strategic planning committee and the joint ADA/ACC “Make the Link” Program. He has played a significant role in developing guidelines for treating diabetes (ADA and AACE), managing chronic disease and clinical trials after a natural disaster and in drawing attention to the global epidemic of diabetes, particularly in Asia.

The American Diabetes Association awarded him the ADA Banting Medal for Leadership and Service and the Southern Medical Association awarded him the Seale – Harris award. He has received several teaching awards and was elected to the Alpha Omega Alpha Honor Medical Society and has been listed among the Best Doctors in the USA, LA and AR.

Dr. Fonseca’s current research includes evaluating inflammation in diabetes, and using technology to improve diabetes care in underprivileged populations. He has been an investigator in several NIH and industry funded clinical trials including the Action to Control Cardiovascular Risk in Diabetes (ACCORD/ ACCORDION) study and TINSAL –2D trial. He is the co–PI of the Louisiana Clinical Data Research Network (LACDRN), funded by PCORI/ PCORNET, serves on the PCORNET Clinical Trials Task Force and is an investigator in several current trials including the NIH funded TACT2 trial.  He serves on several Steering and Ancillary studies committees and Data Safety monitoring boards.

Dr. Fonseca has lectured in the U.S. and abroad. He has published over 300 papers and is the editor of the text book “Clinical Diabetes: Translating Research into Practice” (El Sevier) and several monographs and book chapters.